The global inhalation and nasal spray generic drugs market size accounted for USD 22,720 million in 2024 and is predicted to touch around USD 53,690 million by 2034, growing at a CAGR of 8.98% from 2024 to 2034.
The inhalation and nasal spray generic drugs market is a crucial branch of the pharmaceutical industry. This industry deals in manufacturing and distribution of nasal sprays in different parts of the world. There are several drug classes manufactured by this industry consisting of bronchodilators, combination drugs, corticosteroids, decongestant sprays, antihistamines and some others. The rising incidence of chronic respiratory disorders has boosted the market growth. This market is expected to rise significantly with the growth of the healthcare industry across the globe.
The growing prevalence of asthma and COPD among people has increased the demand for nasal sprays, thereby driving the market growth. Also, the development of oxymetazoline hydrochloride sprays for treating allergic rhinitis along with rising government initiatives aimed at developing the pharmaceutical sector is crucial for the market expansion. Moreover, the availability of these sprays in online and offline platforms is anticipated to proliferate the growth of the inhalation and nasal spray generic drugs market. The growing demand for drug-free nasal sprays along with rise in research and development activities related to nasal sprays is expected to create ample growth opportunities for the market players in the upcoming days.
Published by Deepa Pandey
